LEADER 05582oas 2202029 a 450 001 9910144034803321 005 20251106213014.0 011 $a1099-1557 035 $a(DE-599)ZDB1491218-1 035 $a(DE-599)1491218-1 035 $a(OCoLC)44084438 035 $a(CONSER) 2001212290 035 $a(CKB)954925595523 035 $a(EXLCZ)99954925595523 100 $a20000519a19929999 sy a 101 0 $aeng 135 $aurmnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPharmacoepidemiology and drug safety 210 $a[Chichester] $cJohn Wiley & Sons 215 $a1 online resource 300 $aRefereed/Peer-reviewed 311 08$a1053-8569 531 0 $aPharmacoepidemiol. drug saf. 606 $aPharmacoepidemiology$vPeriodicals 606 $aChemotherapy$vPeriodicals 606 $aEpidemiology$vPeriodicals 606 $aDrugs$xSide effects$vPeriodicals 606 $aDrugs$xSide effects 606 $aDrug utilization 606 $aEpidemiology 606 $aClinical pharmacology 606 $aDrug-Related Side Effects and Adverse Reactions 606 $aDrug Utilization 606 $aEpidemiologic Methods 606 $aEpidemiology 606 $aPharmacology, Clinical 606 $aProduct Surveillance, Postmarketing 606 $aPharmacoe?pide?miologie$vPe?riodiques 606 $aMe?dicaments$xEffets secondaires$vPe?riodiques 606 $aChimiothe?rapie$vPe?riodiques 606 $aE?pide?miologie$vPe?riodiques 606 $aMe?dicaments$xEffets secondaires 606 $aMe?dicaments$xUsage 606 $aE?pide?miologie 606 $aPharmacologie clinique 606 $aPharmacovigilance 606 $aDrugs$xSide effects$2fast$3(OCoLC)fst00898912 606 $aDrug utilization$2fast$3(OCoLC)fst00898740 606 $aClinical pharmacology$2fast$3(OCoLC)fst00864398 606 $aChemotherapy$2fast$3(OCoLC)fst00853595 606 $aEpidemiology$2fast$3(OCoLC)fst00914091 606 $aPharmacoepidemiology$2fast$3(OCoLC)fst01060242 606 $aArzneiverordnung$2gnd 606 $aEvaluation$2gnd 606 $aZeitschrift$2gnd 606 $aOnline-Ressource$2gnd 606 $aArzneimittelnebenwirkung$2gnd 606 $aEpidemiologie$2gnd 606 $aArzneimittelsicherheit$2gnd 606 $aEpidemiologia$2thub 606 $aFarmacologia clínica$2thub 606 $aQuimioteràpia$2thub 608 $aFulltext. 608 $aInternet Resources. 608 $aPeriodicals. 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aRevistes electròniques.$2thub 615 0$aPharmacoepidemiology 615 0$aChemotherapy 615 0$aEpidemiology 615 0$aDrugs$xSide effects 615 0$aDrugs$xSide effects. 615 0$aDrug utilization. 615 0$aEpidemiology. 615 0$aClinical pharmacology. 615 12$aDrug-Related Side Effects and Adverse Reactions. 615 12$aDrug Utilization. 615 12$aEpidemiologic Methods. 615 12$aEpidemiology. 615 12$aPharmacology, Clinical. 615 12$aProduct Surveillance, Postmarketing. 615 6$aPharmacoe?pide?miologie 615 6$aMe?dicaments$xEffets secondaires 615 6$aChimiothe?rapie 615 6$aE?pide?miologie 615 6$aMe?dicaments$xEffets secondaires. 615 6$aMe?dicaments$xUsage. 615 6$aE?pide?miologie. 615 6$aPharmacologie clinique. 615 6$aPharmacovigilance. 615 7$aDrugs$xSide effects. 615 7$aDrug utilization. 615 7$aClinical pharmacology. 615 7$aChemotherapy. 615 7$aEpidemiology. 615 7$aPharmacoepidemiology. 615 7$aArzneiverordnung 615 7$aEvaluation 615 7$aZeitschrift. 615 7$aOnline-Ressource 615 7$aArzneimittelnebenwirkung 615 7$aEpidemiologie 615 7$aArzneimittelsicherheit 615 7$aEpidemiologia. 615 7$aFarmacologia clínica. 615 7$aQuimioteràpia. 676 $a615 712 02$aInternational Society for Pharmacoepidemiology, 712 02$aInternational Society of Pharmacovigilance, 801 0$bOH1 801 1$bOH1 801 2$bNSD 801 2$bOCLCQ 801 2$bMUQ 801 2$bOCL 801 2$bIUL 801 2$bOCLCQ 801 2$bSFB 801 2$bQE2 801 2$bUKMGB 801 2$bVT2 801 2$bOCLCO 801 2$bOCLCF 801 2$bOCLCO 801 2$bOCLCQ 801 2$bNLGGC 801 2$bOCLCO 801 2$bOCLCQ 801 2$bOCLCO 801 2$bOCLCQ 801 2$bDEFHM 801 2$bOCLCO 801 2$bOCLCA 801 2$bZ5A 801 2$bOCLCO 801 2$bOCLCA 801 2$bBUF 801 2$bOCLCQ 801 2$bOCLCA 801 2$bEZC 801 2$bOCLCO 801 2$bU3W 801 2$bOCLCA 801 2$bLND 801 2$bCASUM 801 2$bWYU 801 2$bOCLCO 801 2$bOCLCA 801 2$bDCHUA 801 2$bOCLCA 801 2$bOCLCQ 801 2$bOCLCO 801 2$bOCLCA 801 2$bNJT 801 2$bOCLCA 801 2$bOCLCO 801 2$bUBY 801 2$bOCLCQ 801 2$bOCL 801 2$bUEJ 801 2$bOCLCA 801 2$bOCLCL 801 2$bSXB 801 2$bOCLCQ 906 $aJOURNAL 912 $a9910144034803321 996 $aPharmacoepidemiology and drug safety$92023300 997 $aUNINA